Boston Scientific Recalls HOT AXIOS Stent Systems Due to Deployment and Expansion Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Boston Scientific has initiated a Class I recall for 150 units of its HOT AXIOS Stent and Electrocautery-Enhanced Delivery System following reports of deployment failures.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevice.
What Happened
Boston Scientific Corporation has issued a voluntary recall for its HOT AXIOS Stent and Electrocautery-Enhanced Delivery System. The recall was initiated following increased reports of issues regarding the deployment and expansion of the stent. According to the FDA, the most common outcome of these difficulties is the prolongation of the procedure to exchange the device. However, the most serious foreseeable outcome involves a cascade of events requiring additional endoscopic or surgical intervention to remove the stent and close the puncture site if the first flange fails to deploy or expand.
Which Products Are Affected
The recall specifically affects the HOT AXIOS Stent and Electrocautery-Enhanced Delivery System (8mm x 8mm).
- Material Number (UPN): M00553530
- UDI-DI: 8714729904557
- Quantity: 150 units
- Recall Number: Z-1162-2026
- Affected Lot Numbers: 35985705, 35986358, 36147098, 36147222, 36165642, 36176423, 36190575, 36191222, 36194448, 36218745, 36227778, 36227779, 36241500, 36271259, 36280398, 36293880, 36300839, 36301620, 36343103, 36343104, 36364646, 36425887, 36469811, 36471228, 36491879, 36492660, 36506029, 36510220, 36510221, 36513401, 36513402, 36513403, 36517139, 36517220, 36525208, 36525209, 36525210, 36534514, 36534518, 36536259, 36536480, 36536481, 36551000, 36551001, 36642564, 36642565, 36642756, 36645775, 36663654, 36677842, 36677843, 36682759, 36684887, 36684888, 36730665, 36730666, 36747824, 36747825, 36753898, 36753899, 36757493, 36757494, 36761827, 36766370, 36766371, 36783265, 36792467, 36792468, 36792469, 36792470, 36792471, 36799315, 36815090, 36815092, 36832774, 36833683, 36836357, 36844783, 36845422, 36846169, 36846176, 36851617, 36851792, 36853596, 36865505, 36873631, 36873632, 36873906, 36874863, 36904228, 36904229, 36904230, 36907002, 36907003, 36907004, 36907028, 37102533, 37102534, 37102535, 37102536, 37102537, 37459567, 37459568, 37459569, 37459570, 37463133, 37470670, 37498192, 37511243, 37519095, 37519096, 37844029, 37519097, 37520927, 37530320, 37530321, 37530333, 37533308, 37541933, 37571927, 37571928, 37579364, 37579366, 37579367, 37580630, 37585525, 37585526, 37589261, 37589262, 37594668, 37649481, 37649482, 37649483, 37650631, 37694052, 37699011, 37699012, 37708202, 37779125, 37779126, 37780822, 37780823, 37780824, 37823589, 37823590, 37827568, 37827569, 37833165, 37833176, 37834499.
What You Should Do
Healthcare facilities and distributors should immediately identify and quarantine any remaining inventory of the affected lot numbers. Boston Scientific Corporation, located at 100 Boston Scientific Way, Marlborough, MA 01752, has initiated this recall voluntarily. Providers should follow the firm's specific instructions for the return or exchange of these devices to prevent use in clinical settings.
Why This Matters
This has been classified as a Class I recall, the most serious level of recall, indicating that the device defect could lead to significant medical complications or the need for invasive surgical intervention to correct deployment failures.
Source
Information provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.